Proverum is an Irish medical device company founded in 2016 as a spin-off from Trinity College Dublin. The company is developing a novel treatment solution for patients with symptomatic BPH designed to be safely and effectively performed in a doctor’s office setting in a simple procedure under local anaesthesia. LSV invested in 2022 to support the Company through its pivotal trial and pursuit of regulatory approval for the ProVee system in Europe and the US.
Location: Ireland
Employees: 1-10
Total raised: $80.23M
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | Halo Busin... | hban.org |
| 18.01.2022 | Lightstone... | lightstone... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.08.2025 | Series B | $80.23M | Gilde Heal... |
Mentions in press and media 3
| Date | Title | Description |
| 26.08.2025 | Irish MedTech startup ProVerum raises €68.6 million to advance new treatment for urological conditions | ProVerum, a MedTech startup based in Dublin, has secured €68.6 million in Series B equity financing to advance the commercialisation of its minimally invasive solution for benign prostatic hyperplasia (BPH). The round was led by MVM Partner... |
| - | ProVerum Medical | “The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the p... |
| - | ProVerum Medical | “ProverumMedical” |